Free Content Gadofullerenes and Gadonanotubes: A New Paradigm for High-Performance Magnetic Resonance Imaging Contrast Agent Probes

Authors: Sitharaman, Balaji; Wilson, Lon J.

Source: Journal of Biomedical Nanotechnology, Volume 3, Number 4, December 2007 , pp. 342-352(11)

Publisher: American Scientific Publishers

Buy & download fulltext article:

Free content The full text is free.

View now:
PDF 5,855.4kb 

Abstract:

In this review, the physicochemical properties and biomedical applications of Gd@C60 (gadofullerenes) and Gd@ Ultra-short Single-walled carbon nanotubes (gadonanotubes) are discussed, especially in regard to the unique benefits of this novel class of materials for Magnetic Resonance Imaging (MRI). The introduction of carbon nanotechnology into biomaterial science has created great opportunity for improving medical diagnostics and therapeutics. In this regard, derivatized gadofullerenes and gadonanotubes offer a new nanoscale paradigm for the design of high-performance MRI contrast agent (CA) probes with efficacies up to 100 times greater than current clinical CAs. Studies show that such CAs are well suited for both passive (magnetic labels for cells) and active (pH-sensitive probes) MRI-based molecular imaging. This capability might lead, for example, to the detection of molecular components or processes that are at the cause of disease. The various important physicochemical factors or parameters discussed in this work provide valuable insight into the development of not only other carbon nanostructure-based MRI contrast agents, but for any fullerene-based biomedical application.
More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page